Effects of Anion Exchange Resin as Phosphate Binder on Serum Phosphate and Ipth Levels in Normal Rats

In order to investigate the characteristics of anion exchange resins that may safely and effectively bind dietary phosphate in digestive tract, phosphate binding experiments were carried out in vitro and in vivo with normal rats by comparing anion exchange resins, PAA-B (which has the same chemical structure as Sevelamer® HCl) and Dowe 1x8, with CaCO3. In in vitro phosphate binding experiments, PAA-B bound 32.3% less phosphate than CaCO3 at pH 7. In the rat dietary phosphorus excretion experiments, PAA-B, Dowex 1x8, and CaCO3 increased fecal phosphorus excretion by 62.7, 32.3, and 84.0%, respectively. Famotidine significantly reduced the phosphate binding of CaCO3. When phosphate solution was orally adiministered, PAA-B depressed serum phosphorus augmentations immediately after administration and thereafter effectively depressed serum iPTH. This suggests that anion exchange resins with most primary and secondary amino type anion exchange groups, have bright prospects in the treatment of hyperphosphatemia. (Int J Artif Organs 2000; 23: 243–9)

[1]  H. Gitelman An improved automated procedure for the determination of calcium in biological specimens. , 1967 .

[2]  J. Delmez,et al.  Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  G. Chertow,et al.  Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  L. Raisz,et al.  Effects of renal insufficiency on the parathyroid gland and calcium homeostasis. , 1968, The American journal of physiology.

[5]  C. H. Fiske,et al.  THE COLORIMETRIC DETERMINATION OF PHOSPHORUS , 1925 .

[6]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[7]  L. Schiller,et al.  Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study. , 1989, The Journal of clinical investigation.

[8]  D. Brancaccio,et al.  Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis. Effects on acidosis, on parathyroid function, and on calcemia. , 1989, Nephron.

[9]  E. Slatopolsky,et al.  RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  H. Burt,et al.  Ion-exchange resins as potential phosphate-binding agents for renal failure patients: effect of the physicochemical properties of resins on phosphate and bile salt binding. , 1987, Journal of pharmaceutical sciences.

[11]  E. Slatopolsky,et al.  Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  S. Massry,et al.  TURNOVER OF ENDOGENOUS PARATHYROID HORMONE IN UREMIC PATIENTS AND THOSE UNDERGOING HEMODIALYSIS , 1972, Transactions - American Society for Artificial Internal Organs.